Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Strategy $4.2 billion perpetual stride preferred stock at-the-market offering
The perpetual stride preferred stock is listed on the Nasdaq Global Select Market
Anjoy Foods Group HK$2.4 billion public offering and HKEX listing
We advised Anjoy Foods on its public offering and listing of H shares
CoreWeave $9 billion acquisition of Core Scientific
We are advising CoreWeave on the acquisition
AeroVironment $1.6 billion stock and convertible notes offerings
The concurrent offerings were registered with the SEC
Zscaler $1.725 billion convertible notes offering and capped call transactions
The convertible senior notes are due 2028
Tempus AI $750 million convertible senior notes offering
The 0.75% convertible senior notes are due 2030
Niagara Mohawk Power $1.25 billion senior notes offering
The investment-grade notes are due 2030 and 2055
Valterra Platinum demerger from Anglo American
We advised Valterra Platinum on the U.S. law aspects of the transaction
Honda $3 billion senior notes offering
The investment-grade notes are due 2028, 2030 and 2035
JBS $3.5 billion senior notes offerings and tender offer
The notes are due 2036, 2056 and 2066